Healixia saw the light of day early 2020. Below you find all the past events of Healixia, and - for the sake of completeness - also of the former associations (ACRP, BAPU, BeAPP and BRAS) that joined forces within Healixia. 

Past events

  1. compliance (1).jpeg
    07 December '21

    Healixia conference: Medical Devices

    Online conference.

    This training course is intended for both manufacturers and distributors of medical devices/ in vitro medical devices and will address various questions/issues under the MDR/IVDR.

  2. brano-Mm1VIPqd0OA-unsplash.jpg
    30 November '21

    Webinar - Gene Therapy Clinical Trial Applications: the proof is in the pudding

    Online meeting

    During this session, an overview will be provided of both the overarching European GMO legislation as well as the GMO regulatory framework and procedures in Belgium and how this impacts the Clinical Trial Application process for gene therapy clinical trials in Belgium.

  3. Online meetup.jpg
    23 November '21

    Healixia session - Learnings from the current pandemic: can these benefit patients?

    Free online session.

    In June 2021, Noël Wathion retired as Deputy Executive Director EMA. Over the past two years, he has been able to fully utilize his expertise and management skills to master the consequences of the Covid-19 storm. On November 23, he will share his learnings from the current pandemic with us.

  4. Online sessie2.jpg
    07 October '21

    Expected trends in the CRO industry

    Online meeting

    Speakers: 

    • Prof. Yves Geysels, Dept of Biomedical Sciences, University of Namur
    • Omer Saka - Partner - Life Sciences and Health Care at PricewaterhouseCoopers Advisory, Capital Projects & Infrastructure

  5. classroom_web.jpg
    04 October '21

    Introduction to Regulatory Affairs 2021

    Brussels

    The course is addressed to people new to regulatory affairs who want to acquire a comprehensive foundation; to regulatory professionals wishing to update their knowledge, and to all collaborators working in close relationship with regulatory affairs and wishing to understand the role of the department.

  6. online event_newsletter
    16 September '21

    Healixia webinar: Pharmacovigilance

    Online

    Online meeting about

    • Methods for safety assessment of Covid-19 vaccines at the European level (Xavier Kurz, EMA) incl. Q&A
    • Best practices regarding inspections of the Belgian authorities and remote inspections (Evelien GERITS, Infarama) incl. Q&A

  7. Online sessie2.jpg
    14 September '21

    Recognition of Pharmaceutical Medicine/Clinical Pharmacology as a specialty for MDs in Belgium: a status update.

    Online

    Online meeting

    During this webinar, a status update will be provided on the recognition of Pharmaceutical Medicine/Clinical Pharmacology as a specialty for Medical Doctors in Belgium. 

  8. Online sessie2.jpg
    18 June '21

    Does price transparency for innovative medicines lead to lower prices?

    Webinar

    Speaker: Prof. Dr. Walter Van Dyck

  9. Online sessie2.jpg
    15 June '21

    Understanding biomarkers in immune therapy

    Webinar

    Speaker: 

    • Yannick Waumans - Global Head Pathology, Imaging and Quantification at CellCarta

  10. online event_newsletter
    27 May '21

    Session on Food supplements

    Webinar

    Confirmed speakers:

    • Leen Rasschaert - FAVV-AFSCA
    • Valerie Vercammen - be-sup
  11. General Meeting.jpg
    21 May '21

    Healixia General Assembly (members only)

    Online

    On the agenda: 

    • activity report and financials Healixia 2020
    • approval action plan and budget 2021
  12. Online sessie2.jpg
    20 May '21

    From EMA authorization to market access in Luxembourg

    Webinar

    Speakers: 

    • Anna Chioti - Head of Division Pharmacy and Medicines at Luxembourg Health Directorate
    • Sonia Franck - Secretary-General at APL

  13. online event_newsletter
    04 May '21

    Falsified Medicines Directive (FMD) – 2 years later (online)

    Webinar

    Speakers:

    • Jean-Pierre Engels - General Manager of the Belgian Verification Organisation
    • Jan Depoorter - Expert FMD - Europe at APB
    • Morgane franck - Quality Manager/QP/RP - Movianto
  14. Online sessie2.jpg
    23 April '21

    Digitization within Medicine, the Belgian eHealth case

    Speaker: 

    Frank Robben, general manager of the Crossroads Bank for Social Security.

  15. Online sessie2.jpg
    23 March '21

    The evolving role of MSLs

    Speaker: Samuel Dyer - CEO and Chairman of the Medical Science Liaison Society and author of several publications, articles, and an Amazon #1 Best Selling book on the subject of the MSL career.

  16. Online sessie2.jpg
    16 March '21

    Towards a global implementation of eConsent in clinical trials

    Speakers:

    • Lou Guffroy, Dept of Biomedical Sciences, University of Namur
    • Prof. Yves Geysels, Dept of Biomedical Sciences, University of Namur
  17. Online sessie2.jpg
    11 February '21

    Public Affairs & Medical Affairs, pharma’s perfect couple

    Speaker: 

    Stefaan Fiers - Head Corporate Communications, Public Affairs and Patient Advocacy at Takeda Belgium

  18. Online sessie2.jpg
    21 January '21

    The Sustainable Development Goals: impact on our business and your job

    Sustainable Development Goals are ubiquitous, also in the pharmaceutical industry. But how do organisations incorporate the SDGs? And what influence does this have on the individual employee? 

  19. Clinical.jpg
    08 December '20

    Impact of Covid-19 on clinical trial execution

    Speakers:

    • Muriel Lins
    • Teresa Lamantia
  20. classroom_web.jpg
    03 December '20

    Session Medical Devices (online)

    On the agenda:

    • State of play on MDR and IVDR implementation
    • Medical Devices Regulations: Should the pharma industry be concerned?
    • Lessons learned from the first MDR and IVDR projects 
    • Evaluation old pact and elements new pact: Industry perspective
  21. Traject - website bij events.jpg
    30 November '20

    Healixia webinar - Patient preference and engagement: reality or myth?

    Speakers:

    • Isabelle Huys and Rosanne Janssens (KU Leuven)
    • Danielle Derijcke (MSD Belgium). She will speak on behalf of EUPATI Belgium.
  22. medical.png
    27 November '20

    The evolving role in Medical affairs: our increasing role in market access (online)

    With Patricia van Dijck - Market Access & Public Affairs Director at GSK Belux

  23. Traject - website bij events.jpg
    24 November '20

    Healixia webinar - Value based pricing: are outcome-based market entry agreements the future?

    Healixia's journey - let's connect: webinar 

  24. Traject - website bij events.jpg
    16 November '20

    Healixia webinar - The scientific approach to a virus epidemic

    Healixia's journey - let's connect: webinar 

  25. Traject - website bij events.jpg
    13 November '20

    Healixia webinar - Advanced therapies: the demise of alchemy and rise of pharmacology

    Healixia's journey - let's connect: webinar 

  26. Traject - website bij events.jpg
    10 November '20

    Healixia webinar - Pioneering malaria challenge trials in Belgium: from theory to practice in a Phase I unit

    Healixia's journey - let's connect: webinar 

  27. Online sessie2.jpg
    22 October '20

    CTR Session (online)

    On the agenda:

    • Implementation CTR EU and national 
    • EU PD Portal: status update 
    • Future training 
    • Role of the College and ethics committee
    • Pilot projects with reflections from:
      • FAMHP
      • Academic sponsors
      • Industry
  28. Traject - website bij events.jpg
    14 October '20

    Healixia's journey - Let's connect

    We invite you to our Healixia's journey - let's connect: multiple webinars from our 4 domains: whenever and wherever you want!

  29. online event_newsletter
    05 October '20

    Video on demand Pharmacovigilance

    We offer you the opportunity to follow the session Pharmacovigilance on demand. Be careful: once you have registered, you will have to pay for this session. 

  30. online event_newsletter
    29 September '20

    Session Pharmacovigilance (online)

    This session has been organized for years by the domain 'Regulatory affairs' and is highly rated by participants of previous editions. This year the following themes will be discussed: 

    • Pharmacovigilance Signals
    • Pharmacovigilance inspections: preparation and inspection 
    • Business continuity planning

  31. classroom_web.jpg
    28 September '20

    Introduction to Regulatory Affairs 2020 (complete)

    Brussels

    The course is addressed to people new to regulatory affairs who want to acquire a comprehensive foundation; to regulatory professionals wishing to update their knowledge, and to all collaborators working in close relationship with regulatory affairs and wishing to understand the role of the department.

  32. medical.png
    25 September '20

    The Anticancer Fund – starts where others stop (online)

    This will be an online session.

    Speakers:

    • Dr. Guy Buyens, Medical Director
    • Dr. Gabry Kuijten, Coordinating Physician, My Cancer Navigator
  33. lecture.jpg
    22 September '20

    Digitization of research sites for clinical research: challenges and opportunities (online)

    This will be an online session.

    Digital transformation of a research site is a complex, resource-intensive, and lengthy undertaking with many challenges, that can cover the entire process of clinical research allowing data to be used much more effectively and efficiently for patient-centered research.

  34. Online meetup.jpg
    29 April '20

    Healixia online meetup: the impact of COVID 19 on the FAMHP

    During this online meetup, we will look into the impact of COVID 19 on the FAMHP and FAMHP related topics.
    You can ask your work-related questions concerning the COVID 19-crisis to Greet Musch, General-director at FAMHP.

  35. 02 March '20

    BeAPP Professional Development Meeting

  36. medical.png
    07 February '20

    Lunchmeeting: Medical Affairs Competence Profile, developed by NVFG

    Brussel

    The responsibilities and visibility of the Medical Affairs Department continue to increase, and Medical Affairs departments are growing in size and budgets.

    New roles, such as the MSL, have been created and responsibilities are being shifted within the department.

  37. HEALIXIA-NYE2020.png
    23 January '20

    New Year's Event

    Brussel

    New Year's event  Ri De Ridder - "Why our health care should perform much better"

  38. 03 December '19

    BRAS Session on Medical Devices 2019

  39. 29 November '19

    Belgium, a magnet for life sciences, thanks to ambitious choices

  40. 28 November '19

    BRAS Advanced Course CTD module 3 - Quality section 2019

  41. 26 November '19

    Shortage of drugs (including unavailability's FAMHP platform)

  42. 14 October '19

    BRAS Symposium 2019

  43. 27 September '19

    KCE Trials

    KCE Trials, Frank Hulstaert, KCE

  44. 24 September '19

    BRAS Session Pharmacovigilance 2019

  45. 04 June '19

    Launch event ACRP.be/BeAPP/BRAS

  46. 04 June '19

    Joint Event ACRP.be, BeAPP and BRAS

  47. 21 May '19

    BRAS General Meeting 2019

  48. 13 May '19

    BRAS Introduction to Regulatory Affairs 2019

  49. 10 May '19

    University Curricula in Belgium: prepared for the future!?

  50. 22 February '19

    2019 FAMHP update

    Update by Greet Musch, FAMHP

  51. 17 January '19

    BeAPP new years? event ?After a career abroad. One year back in Belgium : my observations and reflections?

  52. 13 December '18

    BRAS Session on Medical Devices

  53. 07 December '18

    Challenges and opportunities for medical Apps in Belgium

  54. 04 December '18

    BRAS session on Market Access

  55. 22 October '18

    BRAS Symposium 2018

  56. 19 October '18

    How is PATIENT ENGAGEMENT changing the pharma industry?

  57. 25 September '18

    BRAS Session on RMP / RMA

  58. 11 September '18

    Session 2018 on Clinical Trials

  59. 21 June '18

    Stay tuned with the latest developments within Regulatory Affairs: an overview of the latest legislation and guidelines

  60. 15 June '18

    Novelties in pharmacology 2017-2018

  61. 14 June '18

    Introduction to regulatory and legal framework for biobanks

  62. 28 May '18

    BRAS Introduction to Regulatory Affairs 2018

  63. 27 April '18

    KCE and KCE Trials, an update

  64. 22 March '18

    Presentation on 'Journey of a Data Privacy Officer: industry perspectives and experience gained from the new EU GDPR'

  65. 02 March '18

    2nd Medical Affairs Day

  66. 02 February '18

    Update on Clinical Trials in Belgium

  67. 18 January '18

    BeAPP New Years? Event: A wealth of compounds in development in onco-immunology : hope for patients but a challenge for commercial succes

  68. 14 December '17

    Session on clinical trials - NEW DATE

  69. 05 December '17

    Pharmacovigilance 2017

    Update on Pharmacovigilance topics

  70. 28 November '17

    Session on Medical Devices 2017

  71. 17 November '17

    The Pact of the Future and its impact on the Belgian Healthcare Landscape

  72. 16 November '17

    BRAS Advanced Course CTD module 3 ? Quality section

  73. 24 October '17

    BRAS Symposium 2017

  74. 22 September '17

    Sunshine Act: what?s in it for me as pharmaceutical professional?

  75. 21 September '17

    Workshop on Market access in a hospital environment ? future challenges

  76. 16 June '17

    The Belgian Commission for Medicines for Human Use

  77. 13 June '17

    Session on Veterinary matters

  78. 16 May '17

    Session on borderline products (medicinal products/medical devices/food supplements/etc.)

  79. 08 May '17

    Introduction to Regulatory Affairs - 2017

  80. 21 April '17

    Rare diseases

    Lunch session on rare diseases

  81. 28 March '17

    Presentation of the ?Trait? de droit pharmaceutique? + BRAS General Meeting

  82. 14 March '17

    BRAS Workshop on Art. 81 agreements with the authorities

  83. 10 March '17

    MSL, MA, MM, MAM, MD ?. this is your day

  84. 31 January '17

    Session on Counterfeiting

  85. 19 January '17

    New Year's event

    Medical Affairs New year's events 2017

  86. 16 December '16

    The future health ecosystem ? The new rules to win

  87. 01 December '16

    The evolving sickness funds - Final Programme

  88. 24 November '16

    BRAS Symposium 2016

    Annual BRAS Symposium 2016

  89. 15 November '16

    Data generation and eHealth?

  90. 06 October '16

    Clinical Trial session 2016

  91. 28 September '16

    How to integrate the Belgian price measures in ...

  92. 23 September '16

    Health Policy in Belgium

    Lunch meeting on health policy in Belgium

  93. 17 June '16

    Business acumen for medical department members

  94. 14 June '16

    Regulatory Data Management

  95. 17 May '16

    BRAS Introduction to Pricing & Reimbursement in Belgium

  96. 12 May '16

    Introduction to Regulatory Affairs

  97. 29 April '16

    FAGG update

    Update from FAMHP 2016

  98. 28 April '16

    Market Access - A practical advanced workshop on Health Economics

  99. 26 April '16

    Workshop from Auto-Control to Co-Responsibility

  100. 03 March '16

    Medical Devices session

  101. 26 February '16

    How is EMA/Europe Impacting our life in the Belgian pharma industry?

  102. 26 January '16

    BRAS General Meeting + dinner

  103. 01 January '16

    Market Access Workshop on Generic Entry

  104. 26 November '15

    Pharmacovigilance session

  105. 19 November '15

    Advanced Course CTD Mod 3

  106. 22 October '15

    BeAPP Educational Program Session 2

  107. 13 October '15

    BRAS Symposium 2015 - Patient of the future: role of regulatory affairs

  108. 29 September '15

    Clinical trial session 2015

  109. 25 September '15

    BeAPP Expert meeting ?Communication?

  110. 10 September '15

    Workshop on Budget Impact Calculation

  111. 12 June '15

    BeAPP Expert meeting & General Assembly

  112. 07 May '15

    Introduction to Regulatory Affairs 2015

  113. 02 April '15

    BRAS Workshop on Biopharmaceuticals

  114. 27 March '15

    BeAPP Expert meeting ?eHealth?

  115. 26 March '15

    Social Media

    SOCIAL MEDIA IN THE PHARMACEUTICAL/MEDICAL DEVICES INDUSTRIES-SESSION 26 MARCH 2015

  116. 23 February '15

    Advanced Course CTD Mod 5

  117. 03 February '15

    BRAS General Meeting + Dinner

  118. 19 December '14

    New Year's Event

    Medical Affairs New year's event

  119. 09 December '14

    Promotional Material

    BRAS session on Promotional Material

  120. 04 December '14

    BRAS Workshop on Registries, observational studies and ...

  121. 13 October '14

    TOPRA Annual Symposium

  122. 02 October '14

    Introduction to Pricing & Reimbursement in Belgium

  123. 23 September '14

    Market Access in a hospital environment

  124. 19 June '14

    Market Access - Workshop on Art. 81

  125. 17 June '14

    BRAS session on ASMF (Active Substance Master File)

  126. 06 June '14

    Engagement with medical experts and patient centricity

  127. 22 May '14

    Introduction to Regulatory Affairs - 2014

  128. 21 May '14

    The new European Regulation on Clinical Trials: An opportunity for Belgium to consolidate its leading position

  129. 13 May '14

    BRAS General Meeting & 25th Anniversary

  130. 24 April '14

    Advanced Therapies and Personalised Medicines

  131. 28 March '14

    Status update on Pharmaceutical Medicine & General Assembly

  132. 20 March '14

    17th International Conference on Pharmaceutical Medicine (ICPM 2014)

  133. 13 March '14

    Medical Devices session : new Belgian legislation and update on ...

  134. 20 December '13

    New Years? Event (BeAPP members only)

  135. 03 December '13

    BRAS Workshop on Budget Impact Calculation

  136. 29 November '13

    Lunch meeting ? The Initiative to Promote Clinical Trials in Belgium

  137. 21 November '13

    Advanced Course CTD Module 3

  138. 14 November '13

    BRAS Symposium 2013

    BRAS European symposium 2013

  139. 24 October '13

    Pharmacovigilance

    Session on Pharmacovigilance 

  140. 27 September '13

    Lunch meeting ? When does your Medical App becomes a medical device ? And what are the consequences for roll-out ?

  141. 24 September '13

    Clinical Trials - Practical aspects

  142. 25 June '13

    Variations

    Session on Variations with FAMHP

  143. 06 June '13

    Lunch meeting ? is there still a role for pharma ?

  144. 28 May '13

    Risk Management Plans And Risk Minimization Activities: An update!

  145. 23 May '13

    Introduction to Regulatory Affairs

  146. 30 April '13

    BRAS General Meeting

  147. 22 April '13

    The Belgian pharmaceutical conference 2013

  148. 28 March '13

    The Sources of the Pharmaceutical Law

  149. 22 March '13

    Lunch meeting ? Medical Science Liaisons (MSL) challenges and opportunities

  150. 25 January '13

    New Year's event -Evidence based alchemy-